你即將離開本站

並前往https://oncology.medicinematters.com/asco-2021/lung-and-thoracic-tumors/impower010-trial-adjuvant-atezolizumab-nsclc/19229338

Adjuvant atezolizumab delays recurrence in early-stage ...

ASCO 2021 : IMpower010 results show a significant DFS benefit with adjuvant atezolizumab versus best supportive care in people with stage ...

確定！ 回上一頁

查詢 「ASCO 2021」的人也找了：

  1. ASCO 2021 Abstract
    2.
  2. asco年會
    3.
  3. ASCO 2020
    4.
  4. ESMO 2021
    5.
  5. ASCO 2022
    6.
  6. ASCO GI 2021
    7.
  7. ASCO 2021 virtual Meeting
    8.
  8. ASCO 2021 registration
    9.